SEC Filings

SEC Filings

Email page PDF view Print view Email Alert Social media sharing

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13G 2/14/2017
13-D SC 13G 2/14/2017
13-D SC 13G/A 2/13/2017
8-K 8-K 2/3/2017 2/2/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Registration Statement S-8 2/2/2017
Registration Statement S-8 2/2/2017
13-D SC 13G/A 1/12/2017
13-D SC 13G 1/12/2017
8-K 8-K 1/10/2017 1/5/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; and Financial Statements and Exhibits.
13-D SC 13D/A 1/10/2017
8-K 8-K 12/21/2016 12/15/2016
Abstract: On Dec. 21, registrant announced the closing of its underwritten public offering of securities for gross proceeds of $11.5 million, which includes the full exercise of the underwriters’ over-allotment option to purchase additional shares and warrants. Registrant reported the results of its annual meeting of stockholders held Dec. 15. The certificate of designation was included by exhibit.
8-K 8-K 12/19/2016 12/15/2016
Abstract: On Dec. 16, registrant announced the pricing of an underwritten public offering of securities for gross proceeds of $10 million, prior to deducting underwriting discounts, commissions and offering expenses payable by the registrant. The underwriting agreement was included by exhibit.
13-D SC 13G 12/19/2016
Prospectus 424B4 12/19/2016
Registration Statement 8-A12B 12/19/2016
Abstract: Registrant filed a description of its common stock warrants, incorporated by reference into its registration statement on Form S-1, in order to register them under the Securities Exchange Act of 1934.
Registration Statement S-1/A 12/15/2016
Abstract: Registrant filed amendment No. 4 to its registration statement to file additional information in connection with its offering for up to $27.6 million of certain types of securities.
Registration Statement S-1/A 12/14/2016
Abstract: Registrant filed amendment No. 3 to its registration statement to file additional information in connection with its offering for up to $20.7 million of certain types of securities.
8-K 8-K 11/30/2016 11/29/2016
Abstract: Registrant reported that on Nov. 29, it made available an updated corporate presentation. The presentation was included by exhibit.
Registration Statement S-1/A 11/30/2016
Abstract: Registrant filed amendment No. 2 to its registration statement to file additional information in connection with its offering for up to $20.7 million of certain types of securities.
Registration Statement S-1/A 11/14/2016
Abstract: Registrant filed amendment No. 1 to its registration statement to file additional information in connection with its offering for up to $20.7 million of certain types of securities.

Displaying 1 to 20 (of 147 filings)